Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. IHH Healthcare launches ‘Global Incubator Programme’ for startups 2. Melco launches integrated resort hospital at Studio City Macau 3. NUH, Siemens to study ultrasound tech for liver disease diagnostics 4. Hong Kong moves forward with Chinese Medicine Development Blueprint 5. SGH to establish regional centre for robotic-assisted orthopaedic surgeryResource Center
Read Here
Advertise
Sign Up
Event News
Healthcare Asia Awards 2025 Winner: Tanupol Virunhagarun, M.D. of BDMS Wellness Clinic
Tanupol Virunhagarun, M.
